20% of participants had 80% reduction in AHI. the average was 44% reduction in AHI across the spectrum. Pre meeting arranged with FDA.
- Forums
- ASX - By Stock
- IHL
- Ann: IHL-42X positive phase 2 clinical trial results
Ann: IHL-42X positive phase 2 clinical trial results, page-21
-
-
- There are more pages in this discussion • 369 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online